Research Article
Neuroprotective Effects of OMO within the Hippocampus and Cortex in a D-Galactose and Aβ25–35-Induced Rat Model of Alzheimer’s Disease
Figure 12
Effect of OMO on APP, tau, SYP, and caspase-3 protein levels in the hippocampus of D-galactose and Aβ25–35-treated AD rats. The Western blot analysis for APP, tau, SYP, and caspase-3 in the rat hippocampus after OMO treatment. The graphs show the levels of (b) APP, (c) tau, (d) SYP, and (e) caspase-3 when compared to the GAPDH levels. These values are expressed as mean ± SD, n = 6. , compared with the normal control group; and , compared with the model group.
(a) |
(b) |
(c) |
(d) |
(e) |